Bristol-Myers Squibb
-
Bristol Myers Squibb’s CheckMate -743 phase 3 trial of Opdivo in combo with Yervoy to treat malignant pleural mMesothelioma meets primary endpoint
65 0Bristol-Myers Squibb announced that CheckMate -743, a pivotal phase 3…
Read more